These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms. Maronese CA; Moltrasio C; Marzano AV Dermatol Clin; 2024 Apr; 42(2):247-265. PubMed ID: 38423685 [TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management. Yan A; Gallardo M; Savu A; Kaffenberger B Arch Dermatol Res; 2024 Jun; 316(7):397. PubMed ID: 38878169 [TBL] [Abstract][Full Text] [Related]
11. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy. Koshelev MV; Garrison PA; Wright TS Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007 [TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor Antagonists in the Treatment of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Syndrome. Saint-Georges V; Peternel S; Kaštelan M; Brajac I Acta Dermatovenerol Croat; 2018 Jun; 26(2):173-178. PubMed ID: 29989876 [TBL] [Abstract][Full Text] [Related]
13. PASH syndrome associated with osteopoikilosis. Gracia-Cazaña T; Frias M; Roselló R; Vera-Álvarez J; Gilaberte Y Int J Dermatol; 2015 Sep; 54(9):e369-71. PubMed ID: 26175185 [No Abstract] [Full Text] [Related]
14. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne. Vinkel C; Thomsen SF Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207 [TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Shenefelt PD Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710 [TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum associated with ulcerative colitis: A recalcitrant case responded to adalimumab with granulocyte and monocyte adsorption apheresis. Isami Y; Kawase Y; Kondo A; Akita W; Yasuda K; Matsutani T; Mitsui H J Dermatol; 2020 May; 47(5):e213-e215. PubMed ID: 32162361 [No Abstract] [Full Text] [Related]
18. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways. Satoh TK J Dermatol; 2024 Feb; 51(2):160-171. PubMed ID: 38031879 [TBL] [Abstract][Full Text] [Related]
19. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis. Kawakami T; Yamazaki M; Soma Y Am J Gastroenterol; 2009 Sep; 104(9):2363-4. PubMed ID: 19727102 [No Abstract] [Full Text] [Related]
20. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Kanekura T; Kawahara K; Maruyama I; Kanzaki T Ther Apher Dial; 2005 Aug; 9(4):292-6. PubMed ID: 16076369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]